|Bid||0.1400 x 0|
|Ask||0.1450 x 0|
|Day's Range||0.1250 - 0.1700|
|52 Week Range||0.0500 - 0.2050|
|Beta (3Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Cannara Biotech Secures $6 Million Mortgage Financing Facility with Canadian Imperial Bank of Commerce
VANCOUVER , Sept. 12, 2019 /CNW/ - Cannara Biotech Inc. ("Cannara Biotech" or the "Company") (LOVE.CN) (OTCQB:LOVFF) (8CB.F), an emerging vertically integrated cannabis company focused on indoor cultivation and sale of premium cannabis and cannabis-infused products, announced it has submitted to Health Canada its site evidence package for Phase One of the Company's cultivation and processing facility in Farnham, Quebec . With construction recently completed, Phase One consists of 170,000 square feet, of which 110,000 is dedicated to indoor cultivation with a capacity of 20,000 kg of premium dried cannabis once the cultivation license is granted. The facility is situated on 27-acres of land located 45 minutes from Montreal and both the facility and the license are held through wholly owned subsidiaries of Cannara Biotech Inc.
Company invites individual and institutional investors, as well as advisors and analysts, to attend real-time, interactive presentations on VirtualInvestorConferences.com VANCOUVER, British Columbia , ...
VANCOUVER , July 25, 2019 /CNW/ - Cannara Biotech ("Cannara" or the "Company") (LOVE.CN) (8CB.F) (OTCQB:LOVFF), an emerging vertically integrated cannabis company focused on the cultivation and sale of dried premium cannabis and cannabis-infused products, today announced financial results for the three month and nine month periods ended May 31, 2019. Closed a Global shopCBD.com Inc. financing in excess of $8 million to support the launch of the online e-commerce platform for the sale and distribution, in the US, of hemp-based CBD products. Subsequent to the quarter, the Company further strengthened its balance sheet with a $2.1 million private placement.
CannTrust Holdings (TSX: TRST) (NYSE: CTST) has launched a cannabis education portal together with Well.ca. The resource is available to Ontario residents through Well.ca with additional provinces to launch soon. Well.ca will serve as a resource and education center for those interested in exploring medical cannabis, leveraging content, insights and expertise from CannTrust's medical business. […]The post Cannabis Stock News Daily Roundup May 28 appeared first on Market Exclusive.
VANCOUVER , May 24, 2019 /CNW/ - Cannara Biotech ("Cannara" or the "Company") (LOVE.CN) (8CB.F) (CNBTF), an emerging vertically integrated cannabis company focused on cultivation and cannabis-infused products, today announced the appointment of Dr. Sara May , PhD. Dr. May is recognized as an expert in the medical cannabis sector and will bring additional skill sets and help strengthen the Company's Board.
VANCOUVER, May 15, 2019 /PRNewswire/ - Cannara Biotech ("Cannara" or the "Company") (LOVE.CN) (8CB.F) (CNBTF), an emerging vertically integrated cannabis company focused on the cultivation and sale of cannabis and cannabis-infused products to the Canadian and international markets, today announced its common shares are listed for trading on the OTCQB® Venture Market under the trading symbol "CNBTF". The OTC operates financial markets for approximately 10,000 U.S. and global securities. "Cannabis and hemp-CBD markets are global markets, with customers, vendors and investors domiciled across all major industrial nations," said Zohar Krivorot, President and CEO of Cannara.
SUNRISE, Fla., April 30, 2019 -- Profile Solutions, Inc. (OTC Pink: PSIQ) announced today that its wholly owned subsidiary, Elite Products International, Inc. (“Elite”), has.